1/5

FIEO Registered Export Ready

Ondansetron Injection 8mg/4ml

Name: Ondansetron Injection 8mg/4ml
SKU: 8601396
Availability: InStoreOnly

Sold by ancalima lifesciences limited · Manufacturer, Exporter · Murthal, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

Store below 30°C, protect from light

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

IN +3 others

Values shown are for ancalima lifesciences limited.

Compliance & Certifications

ISO 9001:2015

Suitable for

Importers · Distributors · Wholesalers

Murthal Dispatch on request FIEO member

ancalima lifesciences limited

Manufacturer, Exporter · Murthal, Haryana, India

Ancalima is manufacturer & exporter of Cosmetic & Pharmaceutical Formulations.

Registered address: Sonipat, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

View profile All products

Established

1970

Employees

11–30

GST

06AACCP5005B1Z4

IEC code

3395003396

Export markets

IN +3 others

GlobalLinker Member Since

May 2021

Turnover

2500001 - 10000000.

Incorporation Type

On request

ISO 9001:2015 ISO 9001:2015

Product details

What are the specifications of this product?

Overview

Ondansetron InjectionOndansetron Injection is a biocompatible parenteral formulation designed for antiemetic therapy, providing precise 8mg/4ml dosing for rapid onset of action in clinical settings.The 4ml standardized volume ensures repeatable dosing and consistent therapeutic effect.Key Features:Optimized aqueous injectable for rapid systemic absorption8mg active concentration per 4ml unitMaintains stability under ambient and refrigerated storageMinimized injection site irritation via controlled pHAttributes:8mg/4ml for predictable therapeutic efficacyInjectable formulation with controlled viscosityRegulatory-compliant for professional institutional use

Product Description

Composition and Formulation Details

Ondansetron Injection contains pharmaceutically pure Ondansetron hydrochloride in sterile isotonic aqueous solution. Buffering agents maintain pH stability and active potency, while stabilizers prevent degradation, ensuring uniform dispersion and precise dosing upon administration.

Functional Characteristics and Performance

The formulation provides predictable pharmacokinetics and rapid therapeutic onset. Low-viscosity design facilitates smooth intravenous or intramuscular delivery. Chemical and physical stability is maintained under ambient and refrigerated conditions, enabling reliable performance in institutional settings.

Application and Industry Relevance

Ondansetron Injection is suitable for hospitals, clinics, and institutional buyers requiring bulk or OEM supply. Its regulated pharmaceutical status and export-ready packaging support professional B2B procurement, ensuring consistent antiemetic therapy for clinical and institutional use.

Description provided by ancalima lifesciences limited.

Specifications

Active Ingredient	Ondansetron Hydrochloride
Concentration	2mg/ml
Formulation	Sterile injectable solution
Packaging Material	Glass Ampoules
Storage Condition	Store below 30°C, protect from light
Shelf Life	Refer to batch-specific expiry
Administration Route	Intravenous (IV) injection

Use cases

Category	Pharmaceuticals > Injectable Medications > Antiemetic Injections
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	Store below 30°C, protect from light
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ondansetron Injection 8mg/4ml. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is Ondansetron Injection 8mg/4ml suitable for pediatric patients?

A: Ondansetron Injection 8mg/4ml can be used in pediatric patients, but dosage should be determined by a healthcare professional based on the weight and condition of the patient.

Q: Can this Ondansetron injection be administered via routes other than intravenous?

A: Ondansetron Injection 8mg/4ml is formulated primarily for intravenous use; other routes such as intramuscular may require different formulations.

Q: What are the storage conditions to maintain efficacy of this injection?

A: Store Ondansetron Injection 8mg/4ml below 30°C and protect it from direct light to maintain its stability and efficacy.

Q: Are there any special handling instructions for the ampoules?

A: Ampoules should be handled carefully to avoid breakage. Use aseptic techniques while opening for injection preparation.

Q: Is this product compliant with international pharmacopeia standards?

A: Yes, this Ondansetron Injection complies with British Pharmacopoeia (BP) standards ensuring quality and safety.

Question not answered? Ask sellers directly — typical response within 4 hours.